Skip to main content

Pharmacy

By Jeff Lagasse | 11:15 am | October 18, 2023
HHS wants to ensure affordable access for beneficiaries in public programs such as Medicare and Medicaid, and for the uninsured.
By Susan Morse | 09:54 am | October 03, 2023
The drugs selected account for $50.5 billion in Part D gross covered prescription drug costs, or about 20% of the total, CMS says.
By Susan Morse | 11:26 am | October 02, 2023
Drug manufacturers must now enter into an agreement with HHS to take part in the price negotiation process. 
By Jeff Lagasse | 11:05 am | September 25, 2023
The benefits of ketamine, the company says, include interrupting unhealthy thought patterns and increasing neuroplasticity.
By Jeff Lagasse | 03:59 pm | September 21, 2023
The program allows members to save on 50+ generic medications that are typically used by consumers with a discount card.
By Jeff Lagasse | 11:29 am | September 20, 2023
The partnership grew out of a philosophical alignment between the companies, with each citing the desire to simplify access and pricing.
By Jeff Lagasse | 09:23 am | September 19, 2023
The agency says current data does not support the recommended dosage of phenylephrine as an effective decongestant.
By Susan Morse | 04:35 pm | September 18, 2023
Rebates and fees received by PBMs account for 42% of every dollar spent on brand medicines in the commercial market, report says.
By Jeff Lagasse | 11:52 am | September 18, 2023
Improperly listing patents may harm competition from generic alternatives and keep prices artificially high, the FTC says.
By Susan Morse | 10:28 am | September 13, 2023
The vaccines from Pfizer-BioNTech and Moderna will be available later this week, CDC says.